LSE - Delayed Quote • GBp
Advanced Oncotherapy plc (AVO.L)
As of August 30 at 4:23 PM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Michael Jeffrey Sinclair | Executive Chairman | 434.42k | -- | 1942 |
| Mr. Nicolas Serandour | CEO & Executive Director | 502.96k | -- | 1975 |
| Prof. Stephen Myers OBE | Executive Director | 397.72k | -- | 1946 |
| Mr. Ed Lee | COO & President of Europe | -- | -- | -- |
| Mr. Graham Pughe | Senior Vice-President of Accounting | -- | -- | -- |
| Ms. Berengere Pons-Chabord | Senior Vice-President of Corporate Finance | -- | -- | -- |
| Mr. David Navas | Vice President of Investor and Public Relations | -- | -- | -- |
| Ms. Bridget Biggar | Director of Human Resources | -- | -- | -- |
| Ms. Donatella Ungaro | Managing Director of ADAM | -- | -- | -- |
| Ms. Marina Giunta | Head of Physics Group | -- | -- | -- |
Advanced Oncotherapy plc
143 Harley street
Ground floor
London, W1G 6BH
United Kingdom
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 174
Description
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Corporate Governance
Advanced Oncotherapy plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Feb 13, 2024 - Feb 14, 2024
Advanced Oncotherapy plc Earnings Call
Related Tickers
DEMG.L Deltex Medical Group plc
0.1316
-2.52%
SUN.L Surgical Innovations Group plc
0.4800
-4.00%
NXTMH.HE Nexstim Plc
2.1600
-3.14%
IBAB.BR Ion Beam Applications SA
12.86
-0.77%
SEQUA.BR Sequana Medical NV
1.3850
-1.07%
CREO.L Creo Medical Group PLC
36.50
+0.69%
KURN.SW Kuros Biosciences AG
6.99
+1.45%
ALCAR.PA Carmat SA
3.2350
0.00%
SN.L Smith & Nephew plc
976.40
+1.24%
TMDX TransMedics Group, Inc.
89.25
+0.42%